Tang Z P, Wu Z M, Li W B, Wu Y J, Zheng T
Department of Otorhinolaryngology Head and Neck Surgery,Tungwah Hospital of Sun Yat-Sen University,Dongguan,523129,China.
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2020 Jan;34(1):49-52. doi: 10.13201/j.issn.1001-1781.2020.01.012.
To determine whether taking spirolactone orally after H-UPPP may relieve laryngeal edema and complications for patients with obstructive sleep apnea(OSA). Fifty patients with OSA to undergo H-UPPP operation were randomly divided equally to the intervention group(taking spirolactone 20 mg orally twice a day for 7 days after H-UPPP) or the control group, all patients received conventional therapy after H-UPPP including anti-infection, hemostatic treatment, fluid replacement and expectorant by fogged absorption. The pharyngeal wound, diet, sleep and speaking pronunciation of all patients in each group were evaluated every other day in 7 days postoperation. The minimum oxygen saturation of blood(SaO2) during sleep at night each day and the period needed for staphyledema resolution of all patients were recorded and compared between each group. Postoperatively, the intervention group had significantly slighter bleeding at wound site, better sleep and more legible speaking pronunciation than the control group after 3 days to 5 days(<0.05). The wound dehiscence of the intervention group was significantly slighter than the control group within 7 days after operation(<0.05). During 3 days to 7days after operation, the intervention group had a significantly better diet than the control group(<0.05). The average minimum SaO2during sleep at night in the intervention group was significantly higher than that in the control group from 3 days to 5 days post operation(<0.05). Period needed for staphyledema resolution in the intervention group(4.1±1.5) days was significantly shorter than that in the control group(5.9±1.8) days (<0.05). Taking spirolactone orally after H-UPPP may relieve laryngeal edema and complications for OSA patients, and it will also shorten the period needed for staphyledema resolution.
为了确定悬雍垂腭咽成形术(H-UPPP)后口服螺内酯是否能减轻阻塞性睡眠呼吸暂停(OSA)患者的喉水肿及并发症。将50例行H-UPPP手术的OSA患者随机均分为干预组(H-UPPP术后口服螺内酯20mg,每日2次,共7天)和对照组,所有患者H-UPPP术后均接受包括抗感染、止血治疗、补液及雾化吸入祛痰的常规治疗。术后7天内每隔1天对每组所有患者的咽部伤口、饮食、睡眠及说话发音进行评估。记录并比较每组患者术后每天夜间睡眠时的最低血氧饱和度(SaO₂)及所有患者悬雍垂水肿消退所需时间。术后3天至5天,干预组伤口部位出血明显少于对照组,睡眠更好,说话发音更清晰(P<0.05)。术后7天内干预组伤口裂开明显少于对照组(P<0.05)。术后3天至7天,干预组饮食明显优于对照组(P<0.05)。术后3天至5天,干预组夜间睡眠时的平均最低SaO₂明显高于对照组(P<0.05)。干预组悬雍垂水肿消退所需时间(4.1±1.5)天明显短于对照组(5.9±1.8)天(P<0.05)。H-UPPP术后口服螺内酯可减轻OSA患者的喉水肿及并发症,还可缩短悬雍垂水肿消退所需时间。